Octavia Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$487K Sell
1,934
-1,152
-37% -$248K 0.04% 125
2026
Q1
$671K Sell
3,086
-283
-8% -$62.8K 0.06% 102
2025
Q4
$770K Sell
3,369
-445
-12% -$101K 0.07% 100
2025
Q3
$883K Buy
3,814
+881
+30% +$179K 0.09% 91
2025
Q2
$544K Sell
2,933
-714
-20% -$133K 0.06% 107
2025
Q1
$764K Sell
3,647
-119
-3% -$23.1K 0.09% 87
2024
Q4
$669K Buy
3,766
+84
+2% +$15.4K 0.08% 92
2024
Q3
$727K Buy
3,682
+13
+0.4% +$2.43K 0.09% 90
2024
Q2
$629K Buy
3,669
+1,148
+46% +$190K 0.09% 102
2024
Q1
$459K Sell
2,521
-539
-18% -$92.9K 0.07% 121
2023
Q4
$474K Buy
3,060
+758
+33% +$111K 0.08% 122
2023
Q3
$343K Buy
2,302
+159
+7% +$23.3K 0.07% 131
2023
Q2
$289K Buy
2,143
+202
+10% +$29.6K 0.06% 145
2023
Q1
$309K Buy
1,941
+32
+2% +$4.89K 0.07% 130
2022
Q4
$309K Buy
1,909
+53
+3% +$8.13K 0.08% 138
2022
Q3
$249K Sell
1,856
-135
-7% -$19.4K 0.07% 143
2022
Q2
$305K Sell
1,991
-997
-33% -$152K 0.08% 124
2022
Q1
$484K Sell
2,988
-37
-1% -$5.38K 0.11% 103
2021
Q4
$410K Sell
3,025
-177
-6% -$20.9K 0.09% 119
2021
Q3
$345K Buy
3,202
+572
+22% +$65.4K 0.09% 121
2021
Q2
$296K Buy
2,630
+267
+11% +$30.1K 0.08% 135
2021
Q1
$256K Buy
+2,363
New +$253K 0.08% 146

Other funds holding ABBV

Octavia Wealth Advisors's ABBV Position: Q2 2026 in Review

Octavia Wealth Advisors reduced its AbbVie (ABBV) stake by 37% in Q2 2026, selling an estimated $248K and leaving 1,934 shares worth $487K. The position accounts for 0.04% of the portfolio, ranked #125.

Octavia Wealth Advisors first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. The position peaked at $883K in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Octavia Wealth Advisors held 1,934 shares of AbbVie worth $487K as of Q2 2026.
  • Octavia Wealth Advisors sold 1,152 AbbVie shares in Q2 2026, an estimated $248K.
  • AbbVie made up 0.04% of Octavia Wealth Advisors's portfolio in Q2 2026, its #125 holding.
  • Octavia Wealth Advisors first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • Octavia Wealth Advisors's AbbVie position peaked at $883K in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Octavia Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.